MYC and breast cancer: We previously showed that overexpression of AURKA was responsible for drug resistance and predicted an inferior prognosis in breast cancer.13 Here we revealed that AURKA overexpression significantly augmented the expression of FOXM1 and cancer stem cell markers c-Myc and Nanog in breast cancer cells (Figure 1a).